Latest Videos

Dennis J. Selkoe, MD, Co-director of the Ann Romney Center for Neurologic Diseases at Brigham and Women’s Hospital, discusses progress in the development of Alzheimer’s disease treatments that target...
Since the time of Dr. Alois Alzheimer himself, two proteins (beta-amyloid (Aβ) and tau) have become tantamount to Alzheimer's disease (AD). But a Mayo Clinic study challenges the perception that these...
With an aging population medical concerns also are on the rise especially for patients with dementia. A recent study has looked at whether coagulants play a part in patients with atrial fibrillation d...
As the population continues to age and more and more people are diagnosed with Alzheimer's Disease or some other form of dementia researchers are looking into what can be done to stem the tide of furt...
The field of research for alzheimer's disease has changed drastically in just over a year as more is learned about amyloids and their role in patients developing the condition.
By examining more than 3,600 postmortem brains, researchers at Mayo Clinic’s campuses in Jacksonville, Florida, and Rochester, Minnesota, have found that the progression of dysfunctional tau protein d...
Glenn E. Smith, Ph.D., L.P., Neuropsychologist & Professor of Psychology, Mayo Clinic, discusses his work with a team that is identifying conditions which may eventually turn into dementia.
Progressive supranuclear palsy (PSP) is a neurodegenerative disease that in its early stages can be misdiagnosed as Parkinson's disease since both involve loss of motor control and occur later in life...
GM1 gangliosidosis is a rare inherited neurodegenerative disorder characterized by severe cognitive and motor developmental delays resulting in death of most patients at a very young age.
analysis of why a blood test for Alzheimer's disease is needed and the challenges that remain ahead for ensuring that it is accurate.